A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 3, 2015, Pages e88-

  Morris, Katrina A ^a   Waters, Paddy ^a   Woodhall, Mark R ^a   Kuker, Wilhelm ^a   Vincent, Angela ^a   Leite, Maria I ^a   Sen, Arjune ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PREDNISOLONE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; AUTONOMIC DYSFUNCTION; BLOOD CELL COUNT; BRAIN DISEASE; CASE REPORT; CELL ASSAY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; DRUG MEGADOSE; FEMALE; FLACCID PARALYSIS; HUMAN; HYPERALGESIA; HYPOTENSION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LABORATORY TEST; LIMB WEAKNESS; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA EXCHANGE; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SEROLOGY; SHORT SURVEY; SPASTICITY; SPINAL CORD; SPINE RADIOGRAPHY; STEROID THERAPY; TREATMENT DURATION; URINE RETENTION;

EID: 84985001896     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000088     Document Type: Short Survey

References (4)

1. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014;71:276-283. doi: 10.1001/jamaneurol.2013.5857.
2. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014;82: 474-481. doi: 10.1212/WNL.0000000000000101.
3. O'Connor KC, McLaughlin KA, De Jager PL, et al. Self-antigen tetramers discriminate between myelin autoanti-bodies to native or denatured protein. Nat Med 2007;13: 211-217.
4. Reindl M, Di Pauli F, Rostásy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013;9:455-461. doi: 10.1038/nrneurol.2013.118.